Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MANH | FRO |
|---|---|---|
| Price | $205.45 | $53.75 |
| Change today | ▲ 0.64% | ▲ 1.92% |
| Market cap | $11.98B | $11.97B |
| Return, 3 months | +29.9% | +52.3% |
| Return, year to date | +18.5% | +183.1% |
| Return, 1 year | +2.5% | +168.8% |
| P/E (TTM) | 58.9 | 8.1 |
| P/B | 76.1 | 3.8 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 5.82% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 50 | 77 |
| 30-day volatility | 30.0% | 36.7% |
| Max drawdown, 1 year | -43.4% | -21.4% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
